{"id":"standard-vaccination-schedule","safety":{"commonSideEffects":[{"rate":"10-50","effect":"Local injection site reactions (pain, redness, swelling)"},{"rate":"5-15","effect":"Fever"},{"rate":"5-10","effect":"Myalgia"},{"rate":"5-10","effect":"Fatigue"},{"rate":"5-10","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL261657","moleculeType":"Small molecule","molecularWeight":"405.37"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Vaccination schedules consist of multiple doses of vaccines administered at defined intervals to build and maintain protective immunity against targeted pathogens. The schedule is designed to optimize immune response by allowing time between doses for immune memory development, and to provide protection during critical periods of vulnerability across the lifespan.","oneSentence":"A standard vaccination schedule stimulates the immune system to produce antibodies and cellular immunity against specific infectious diseases through sequential administration of vaccines.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:09:37.247Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of infectious diseases including diphtheria, tetanus, pertussis, poliomyelitis, measles, mumps, rubella, hepatitis B, and other vaccine-preventable diseases"}]},"trialDetails":[{"nctId":"NCT03387553","phase":"EARLY_PHASE1","title":"HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2018-06-06","conditions":"Breast Cancer, Breast Cancer Female, Breast Cancer, Male","enrollment":31},{"nctId":"NCT07487077","phase":"PHASE4","title":"Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya","status":"RECRUITING","sponsor":"Albert B. Sabin Vaccine Institute","startDate":"2025-10-31","conditions":"Cholera Vaccination","enrollment":1071},{"nctId":"NCT02287428","phase":"PHASE1","title":"Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2014-11","conditions":"Glioblastoma","enrollment":56},{"nctId":"NCT06387511","phase":"NA","title":"Increasing Measles Vaccination Coverage Through Supplementation With an SQ-LNS Incentive in Children Aged 6-23 Months","status":"COMPLETED","sponsor":"Alliance for International Medical Action","startDate":"2024-05-07","conditions":"Immunization Coverage, Vaccination, Nutrition","enrollment":3814},{"nctId":"NCT07414901","phase":"NA","title":"Group Postpartum and Well-Child Care for Maternal and Infant Health","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-03-30","conditions":"Infant Care, Postpartum Care","enrollment":940},{"nctId":"NCT05590351","phase":"NA","title":"Efficacy of Mobile Health Application in Promotion of Exclusive Breast Feeding and Young Child Feeding Practices in Pakistan","status":"RECRUITING","sponsor":"Aga Khan University","startDate":"2026-02-02","conditions":"Malnutrition, Infant, Malnutrition, Child","enrollment":300},{"nctId":"NCT01644721","phase":"PHASE4","title":"Trial of Additional Measles Vaccine to Reduce Child Mortality","status":"COMPLETED","sponsor":"Bandim Health Project","startDate":"2012-07","conditions":"Measles Vaccine","enrollment":3750},{"nctId":"NCT03656926","phase":"PHASE3","title":"Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2019-03-26","conditions":"Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection","enrollment":169},{"nctId":"NCT07365280","phase":"PHASE2","title":"Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma","status":"NOT_YET_RECRUITING","sponsor":"ZSky Biotech Inc","startDate":"2026-01-09","conditions":"Glioblastoma","enrollment":78},{"nctId":"NCT06547814","phase":"NA","title":"COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2024-08-05","conditions":"COVID-19","enrollment":20},{"nctId":"NCT04294433","phase":"PHASE4","title":"Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children","status":"COMPLETED","sponsor":"Laval University","startDate":"2018-06-11","conditions":"Hepatitis B","enrollment":431},{"nctId":"NCT05926544","phase":"NA","title":"COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2023-10-04","conditions":"COVID-19","enrollment":16},{"nctId":"NCT07328087","phase":"EARLY_PHASE1","title":"COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer","status":"RECRUITING","sponsor":"Biogenea Pharmaceuticals Ltd.","startDate":"2026-02-02","conditions":"Colorectal Cancer Metastatic, Colorectal Cancer Stage III, Colorectal Cancer Stage IV","enrollment":12},{"nctId":"NCT05077254","phase":"PHASE2","title":"COVID Protection After Transplant-Immunosuppression Reduction","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-12-06","conditions":"Kidney Transplant Recipients, Liver Transplant Recipients","enrollment":48},{"nctId":"NCT07316361","phase":"EARLY_PHASE1","title":"GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer","status":"ENROLLING_BY_INVITATION","sponsor":"Biogenea Pharmaceuticals Ltd.","startDate":"2026-02-02","conditions":"Endometrial Carcinoma, Endometrial Carcinoma Stage III","enrollment":40},{"nctId":"NCT07200414","phase":"NA","title":"Strengthening HPV Vaccination and Adolescent Health Research Program in Nigeria (SHARP)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2024-10-01","conditions":"Human Papillomavirus (HPV) Vaccine, Human Papillomavirus (HPV) Vaccines, Human Papillomavirus (HPV) Infections","enrollment":14768},{"nctId":"NCT05886439","phase":"PHASE1, PHASE2","title":"LK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung Cancer","status":"RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2023-05-11","conditions":"Lung Cancer","enrollment":60},{"nctId":"NCT06320535","phase":"PHASE1","title":"A Phase 1 Study to Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Oxford","startDate":"2024-03-25","conditions":"Malaria,Falciparum","enrollment":36},{"nctId":"NCT06626321","phase":"NA","title":"Behavioral Economics to Improve Flu Vaccination Using EHR Nudges Replication","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2024-10-21","conditions":"Behavior, Health, Flu, Flu Vaccination","enrollment":26248},{"nctId":"NCT04982614","phase":"PHASE4","title":"HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini","status":"COMPLETED","sponsor":"Columbia University","startDate":"2022-04-01","conditions":"HPV Infection, Hiv, HPV Vaccine","enrollment":1403},{"nctId":"NCT05557370","phase":"PHASE4","title":"Immunogenicity of HPV Vaccine in Transplant Recipients.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2023-06-01","conditions":"Chronic Kidney Diseases, Kidney Transplant","enrollment":30},{"nctId":"NCT04878328","phase":"NA","title":"Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2022-04-14","conditions":"Covid19","enrollment":250},{"nctId":"NCT05841810","phase":"NA","title":"Working Towards Empowered Community-driven Approaches to Increase Vaccination and Preventive Care Engagement","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Diego","startDate":"2024-08-20","conditions":"COVID-19","enrollment":398},{"nctId":"NCT06156228","phase":"NA","title":"Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos","status":"TERMINATED","sponsor":"San Diego State University","startDate":"2024-03-06","conditions":"Vaccine Hesitancy","enrollment":238},{"nctId":"NCT00911560","phase":"PHASE1, PHASE2","title":"Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral β-glucan for High-Risk Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2009-05-27","conditions":"Neuroblastoma","enrollment":374},{"nctId":"NCT04882514","phase":"PHASE1, PHASE2","title":"A Trial of a Peptide-based Group A Streptococcal (GAS) Vaccine Candidate in Healthy Individuals.","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2022-11-07","conditions":"Group A Streptococcal Infection","enrollment":30},{"nctId":"NCT06057727","phase":"NA","title":"Behavioral Economics to Improve Flu Vaccination Using EHR Nudges","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2023-09-25","conditions":"Behavior, Health, Flu, Flu Vaccination","enrollment":80039},{"nctId":"NCT05535777","phase":"NA","title":"Patient Portal Flu Vaccine Reminders_RCT 5 (LADHS)","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2022-09-13","conditions":"Influenza, Respiratory Tract Infections","enrollment":246295},{"nctId":"NCT05139992","phase":"","title":"COVID-19 Vaccine Response in Sickle Cell Disease","status":"COMPLETED","sponsor":"ASH Research Collaborative","startDate":"2021-12-01","conditions":"Sickle Cell Disease, COVID-19","enrollment":59},{"nctId":"NCT06745635","phase":"NA","title":"A Multifaceted Intervention on Reducing Immunization Errors","status":"NOT_YET_RECRUITING","sponsor":"Hospital Israelita Albert Einstein","startDate":"2025-07-03","conditions":"Vaccines, Vaccines Adverse Reaction, Vaccine Practice","enrollment":72},{"nctId":"NCT02942277","phase":"PHASE1","title":"Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-10-21","conditions":"Malaria","enrollment":301},{"nctId":"NCT02549833","phase":"PHASE1","title":"Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma","status":"COMPLETED","sponsor":"Jennie Taylor","startDate":"2016-10-17","conditions":"Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic","enrollment":28},{"nctId":"NCT06681636","phase":"PHASE2","title":"Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Hygiene and Epidemiology, Vietnam","startDate":"2024-12-14","conditions":"HPV Infection, Cervical Cancer, Anogenital Cancer","enrollment":300},{"nctId":"NCT05119959","phase":"NA","title":"Zambia Infant Cohort Study - Brains Optimized for Surviving and Thriving","status":"COMPLETED","sponsor":"Boston University","startDate":"2022-04-14","conditions":"Child Development","enrollment":469},{"nctId":"NCT03501992","phase":"NA","title":"Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2018-04-01","conditions":"Papillomavirus Vaccines","enrollment":9242},{"nctId":"NCT04785352","phase":"NA","title":"Grandi Byen: Test of an Integrated Parenting and Nutrition Intervention","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2021-07-01","conditions":"Malnutrition, Child, Development, Child, Parenting","enrollment":600},{"nctId":"NCT05537441","phase":"NA","title":"Precision Vaccine Promotion in Underserved Populations","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2022-09-22","conditions":"Influenza, Vaccine Hesitancy","enrollment":228831},{"nctId":"NCT06578572","phase":"PHASE3","title":"Seasonal R21 Mass Vaccination for Malaria Elimination","status":"RECRUITING","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2024-05-30","conditions":"Malaria","enrollment":16200},{"nctId":"NCT06486766","phase":"NA","title":"Effectiveness of SMS Nudging to Increase Coverage of Influenza Vaccination Among the Elderly","status":"NOT_YET_RECRUITING","sponsor":"Norwegian Institute of Public Health","startDate":"2025-10","conditions":"Influenza","enrollment":1000000},{"nctId":"NCT03199040","phase":"PHASE1","title":"Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2019-07-23","conditions":"Triple Negative Breast Cancer, Triple Negative Breast Neoplasms, TNBC - Triple-Negative Breast Cancer","enrollment":18},{"nctId":"NCT05765084","phase":"PHASE1, PHASE2","title":"Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma","status":"RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2023-02-24","conditions":"Malignant Pleural Mesothelioma","enrollment":15},{"nctId":"NCT02728102","phase":"PHASE2","title":"Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2016-07","conditions":"Multiple Myeloma","enrollment":203},{"nctId":"NCT03548571","phase":"PHASE2, PHASE3","title":"Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2018-04-26","conditions":"Glioblastoma","enrollment":60},{"nctId":"NCT05500339","phase":"NA","title":"Effectiveness of a mHealth App for Supporting the First 1000 Days of Life","status":"RECRUITING","sponsor":"IRCCS Burlo Garofolo","startDate":"2022-11-22","conditions":"Health-Related Behavior","enrollment":360},{"nctId":"NCT01311674","phase":"PHASE3","title":"Hepatitis B Virus Antibody Booster Program for the Production of Hepatitis B Immune Globulin (HBIG)","status":"TERMINATED","sponsor":"Emergent BioSolutions","startDate":"2009-09","conditions":"Healthy Volunteers","enrollment":141},{"nctId":"NCT04573205","phase":"PHASE4","title":"Primary TBE Vaccination for the Elderly","status":"UNKNOWN","sponsor":"Region Örebro County","startDate":"2024-01","conditions":"Tick-borne Encephalitis, Vaccine","enrollment":90},{"nctId":"NCT03632720","phase":"PHASE3","title":"Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2018-10-10","conditions":"Healthy Volunteers (Meningococcal Infection)","enrollment":788},{"nctId":"NCT00579423","phase":"PHASE2","title":"Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2000-11","conditions":"Prostate, Cancer","enrollment":30},{"nctId":"NCT06029634","phase":"","title":"Effects of T-bet B Cells in Persistent Virus Control After Discontinuance of NAs in CHB Patients","status":"COMPLETED","sponsor":"Changhai Hospital","startDate":"2020-07-01","conditions":"Chronic HBV Infection, Drug Withdrawal","enrollment":45},{"nctId":"NCT05169905","phase":"PHASE3","title":"A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2022-02-02","conditions":"Respiratory Syncytial Virus Infections","enrollment":9},{"nctId":"NCT04834726","phase":"NA","title":"COVID-19 Vaccine Text Outreach","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2021-04-29","conditions":"Covid19","enrollment":19554},{"nctId":"NCT05778240","phase":"NA","title":"Adherence to Palivizumab Prophylaxis","status":"COMPLETED","sponsor":"Kosuyolu Heart Hospital","startDate":"2020-10-01","conditions":"Congenital Heart Disease in Children, RSV","enrollment":229},{"nctId":"NCT05075122","phase":"PHASE2","title":"Tolerability and Efficacy of UV1 Vaccine in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Planned for First-line Treatment With Pembrolizumab","status":"UNKNOWN","sponsor":"Martin-Luther-Universität Halle-Wittenberg","startDate":"2021-08-02","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":75},{"nctId":"NCT04565353","phase":"NA","title":"Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2020-09-20","conditions":"Influenza, Human","enrollment":74811},{"nctId":"NCT05133609","phase":"PHASE1, PHASE2","title":"COVID-19 VACCINE SAFETY AND EFFECTIVENESS","status":"UNKNOWN","sponsor":"Federal University of Espirito Santo","startDate":"2021-01-15","conditions":"SARS-CoV-2 Infection","enrollment":550},{"nctId":"NCT05059106","phase":"PHASE2, PHASE3","title":"EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19","status":"UNKNOWN","sponsor":"Federal University of Espirito Santo","startDate":"2021-06-01","conditions":"SARS-CoV-2","enrollment":29637},{"nctId":"NCT03695393","phase":"NA","title":"Stigma, Risk Behaviors and Health Care Among HIV-infected Russian People Who Inject Drugs","status":"COMPLETED","sponsor":"Boston Medical Center","startDate":"2019-10-10","conditions":"HIV Infections, Stigmatization, Substance Use","enrollment":100},{"nctId":"NCT01276184","phase":"NA","title":"Effectiveness of SMS (Short Message Service) Text Messaging in Increasing Adherence to Gardasil","status":"TERMINATED","sponsor":"University of Maryland, Baltimore","startDate":"2011-01","conditions":"HPV Vaccines","enrollment":22},{"nctId":"NCT03377127","phase":"NA","title":"Impact of Pharmacy Clinic on Diabetes Management","status":"COMPLETED","sponsor":"Corewell Health East","startDate":"2018-02-19","conditions":"Diabetes Mellitus, Type 2","enrollment":86},{"nctId":"NCT03125616","phase":"PHASE4","title":"Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B","status":"COMPLETED","sponsor":"St George's, University of London","startDate":"2017-08-01","conditions":"Prematurity, Vaccination, Meningococcal Disease","enrollment":136},{"nctId":"NCT04540653","phase":"PHASE4","title":"Immunogenicity of the Hepatitis B Vaccine","status":"UNKNOWN","sponsor":"Universidade Federal de Goias","startDate":"2017-07-29","conditions":"Vaccine Response Impaired, Hepatitis B, Aging","enrollment":240},{"nctId":"NCT04177485","phase":"NA","title":"Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2016-02-01","conditions":"Diphtheria, Tetanus, Pertussis","enrollment":1962},{"nctId":"NCT00617409","phase":"PHASE2","title":"To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2007-10-02","conditions":"Small Cell Lung Cancer","enrollment":69},{"nctId":"NCT03346915","phase":"NA","title":"Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention","status":"COMPLETED","sponsor":"Boston Medical Center","startDate":"2018-08-14","conditions":"Human Papilloma Virus, Cervical Cancer, Human Papillomavirus Infection","enrollment":60},{"nctId":"NCT01433172","phase":"PHASE1, PHASE2","title":"Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2012-03-26","conditions":"Lung Cancer, Adenocarcinoma","enrollment":73},{"nctId":"NCT01388985","phase":"PHASE3","title":"Simplifying the Rabies Pre-exposure Vaccination","status":"COMPLETED","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2011-10","conditions":"Rabies","enrollment":500},{"nctId":"NCT03166254","phase":"PHASE1","title":"Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer","status":"WITHDRAWN","sponsor":"Washington University School of Medicine","startDate":"2019-04-30","conditions":"Non Small Cell Lung Cancer, NSCLC, Non-small Cell Lung Cancer","enrollment":""},{"nctId":"NCT03168412","phase":"PHASE4","title":"A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)","status":"COMPLETED","sponsor":"Xiamen Innovax Biotech Co., Ltd","startDate":"2017-05-25","conditions":"Hepatitis E","enrollment":125},{"nctId":"NCT02710045","phase":"NA","title":"The Interaction Between Measles and DTP Vaccination","status":"COMPLETED","sponsor":"Medical Research Council Unit, The Gambia","startDate":"2007-11","conditions":"Non-target Heterologous Effects of Vaccines, Vaccine Interactions","enrollment":302},{"nctId":"NCT03307642","phase":"NA","title":"Evaluation of the School Kids Influenza Prevention Project","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2017-12-04","conditions":"Childhood Influenza Vaccination, School-located Influenza Vaccination","enrollment":18540},{"nctId":"NCT03402646","phase":"NA","title":"Mobile Phone Reminders (and Photovoice) for Routine Immunization in Nigeria - The MOPING Study","status":"UNKNOWN","sponsor":"Universiti Putra Malaysia","startDate":"2018-05","conditions":"Immunization; Infection","enrollment":1813},{"nctId":"NCT02280967","phase":"NA","title":"Prevention of HPV in the School Health Service","status":"COMPLETED","sponsor":"Uppsala University","startDate":"2014-01","conditions":"Human Papillomavirus, Cervix Cancer","enrollment":832},{"nctId":"NCT00806676","phase":"NA","title":"Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2008-12","conditions":"Chronic Kidney Disease","enrollment":67},{"nctId":"NCT02115516","phase":"PHASE1","title":"Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis","status":"COMPLETED","sponsor":"Sanaria Inc.","startDate":"2014-04","conditions":"Malaria, Plasmodium Falciparum Malaria","enrollment":67},{"nctId":"NCT00841477","phase":"PHASE3","title":"An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2004-01","conditions":"Hepatitis B Infection, Hepatitis C Infection, HIV Infection","enrollment":1260},{"nctId":"NCT02208960","phase":"PHASE3","title":"Newborn Kit to Save Lives and Brains in Kenya","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2014-11","conditions":"Neurodevelopment, Neonatal Mortality","enrollment":2294},{"nctId":"NCT02382900","phase":"PHASE3","title":"Two-dose Schedule of Quadrivalent HPV Recombinant Vaccine in 11-year-old Boys in Mexico City","status":"UNKNOWN","sponsor":"Universidad Nacional Autonoma de Mexico","startDate":"2015-02","conditions":"Human Papilloma Virus","enrollment":500},{"nctId":"NCT01617239","phase":"PHASE1","title":"Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine","status":"COMPLETED","sponsor":"Crucell Holland BV","startDate":"2012-06","conditions":"Influenza","enrollment":84},{"nctId":"NCT01405677","phase":"PHASE2","title":"Safety and Immunogenicity of a Paediatric Dose of Virosomal Hepatitis A Vaccine","status":"COMPLETED","sponsor":"Crucell Holland BV","startDate":"2004-06","conditions":"Hepatitis A","enrollment":308},{"nctId":"NCT01000363","phase":"","title":"Diabetes Group Visits","status":"COMPLETED","sponsor":"Emory University","startDate":"2009-11","conditions":"Diabetes","enrollment":92},{"nctId":"NCT00825305","phase":"PHASE3","title":"Safety and Immunogenicity (Non-inferiority) of a Purified Chick Embryo Cell Vaccine Vaccine Administered in Two Different Schedules (Conventional Versus Abbreviated Schedule)","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2008-11","conditions":"Rabies","enrollment":825},{"nctId":"NCT01259453","phase":"PHASE4","title":"Hepatitis B Vaccination Through Syringe Exchange Programs: A Randomized, Controlled Trial of Vaccination Schedules","status":"COMPLETED","sponsor":"Yale University","startDate":"2003-05","conditions":"Hepatitis B","enrollment":595},{"nctId":"NCT01055990","phase":"PHASE2","title":"Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients","status":"UNKNOWN","sponsor":"Shanghai Public Health Clinical Center","startDate":"2009-10","conditions":"Virus Diseases, Respiratory Tract Diseases, Respiratory Tract Infections","enrollment":7},{"nctId":"NCT00424944","phase":"PHASE1","title":"Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine","status":"UNKNOWN","sponsor":"African Malaria Network Trust","startDate":"2007-06","conditions":"Malaria","enrollment":40},{"nctId":"NCT00168662","phase":"PHASE4","title":"Non-Specific Effects of Standard Titre Measles Vaccination","status":"COMPLETED","sponsor":"Bandim Health Project","startDate":"1995-03","conditions":"Measles","enrollment":7800},{"nctId":"NCT00602056","phase":"NA","title":"Low Cost Interventions to Improve Adherence to Childhood Immunization Schedule","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2005-11","conditions":"Childhood Immunization Completion, Childhood Immunization Dropout, Immunization Card","enrollment":1506},{"nctId":"NCT00559026","phase":"PHASE1","title":"Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients","status":"COMPLETED","sponsor":"Istituto Superiore di Sanità","startDate":"2004-09","conditions":"Melanoma","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Standard vaccination schedule","genericName":"Standard vaccination schedule","companyName":"Universidade Federal de Goias","companyId":"universidade-federal-de-goias","modality":"Biologic","firstApprovalDate":"","aiSummary":"A standard vaccination schedule stimulates the immune system to produce antibodies and cellular immunity against specific infectious diseases through sequential administration of vaccines. Used for Prevention of infectious diseases including diphtheria, tetanus, pertussis, poliomyelitis, measles, mumps, rubella, hepatitis B, and other vaccine-preventable diseases.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}